| Biotechnology Industry | Healthcare Sector | Mr. Xiaojun Liu CEO | XSHE Exchange | CNE100004181 ISIN |
| China Country | 295 Employees | 10 Jul 2026 Last Dividend | 30 Jun 2023 Last Split | - IPO Date |
Beijing Scitop Bio-tech Co., Ltd. is a prominent enterprise specializing in the research, development, manufacture, and sales of probiotic lactic acid bacteria and their related products within China's borders. Founded in the year 2003 and having its headquarters positioned in Beijing, the country's capital, the company champions the integration of scientific research with biotechnological advancements to cater to various sectors, including the food industry, health care, animal husbandry, and agricultural planting. Its commitment to innovation and quality has placed Beijing Scitop Bio-tech at the forefront of bio-tech companies in China, aiming to enhance human health and agricultural productivity through microbial solutions.